Medtronic's (NYSE:MDT) stand-alone diabetes company, first announced in May, will be known as MiniMed. MiniMed was the ...

Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity ...

Medtronic has announced plans to separate out its diabetes business into a new standalone company. The separation will serve to create an “independent, scaled leader in diabetes” that boasts ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a standalone company. The new diabetes company will focus on accelerating ...

Medtronic plc MDT announced on May 21 its plans to separate its Diabetes business into a separate, publicly traded company. The separation will occur via a two step transaction a ...

The move will let the med-tech giant focus on areas like cardiovascular, neurological and surgical devices. Medtronic wins FDA OK for deep brain Parkinson's treatment Medtronic beats Q2 ...

Medtronic’s decision to spin out its diabetes division into a separate entity marks a major shift — one that allows the medical device giant to shed a lower-margin, consumer-facing business ...

Medtronic, which announced last month it will spin off its $2.8 billion diabetes unit as a standalone public company, has ...

Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of ...

Medtronic (NYSE:MDT) announced that it inaugurated a new Diabetes Global Capability Center in India with a significant ...

Medtronic said. The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year, ending in April, up 10.7% from the prior year. Medtronic reported more than $34 billion ...